Skip to content

ESCULAPE

Active Private limited companyfounded 1997active for 28 yearsRue du Vivier 37, 4950 WaimesKBO/BCE: BE 0462.295.367

Lifetime

20 annual accounts with figures on one time axis, 28 filings since 1998
peak €122,174 (2011)
€73,113▲ 39.4%
lowest -€14,153 (2020)
€23,522▲ 34.2%
peak €307,645 (2010)
€263,751▼ 8.6%
€61,036▲ 61.0%
Board1 name since 2021
1 director
Documentsfilings and deeds
16-09-202647 days late
2025micro format
Gross margin from €52,462 to €73,113Result from €17,522 to €23,522Dividend €48,233Debts from €37,910 to €61,036

Key points

from the 2025 annual accounts

Equity

€263,751 ▼ 8.6%
288,4622024+23,522Profit-48,233Dividend263,7512025

ESCULAPE paid out €48,233 in dividends. That is 205% of the 2025 profit.

Investments

€50,979 1.8 × depreciation
20212022202320242025

Green is investment, beige is depreciation. Machinery stands 124.3% higher than in 2024.

Filings

28 annual accounts since 1998
AprilJune31 JulyOctober200020102020

Seven of the last ten came late. The 2023 accounts came latest: 64 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,386 companies had the same profile as ESCULAPE has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,386 companies, not a prediction for ESCULAPE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0462295367
Change of role: , from manager to director Gazette deed
Incorporation published on 09-01-1998 · Gazette deed
All 36 events

Comparable companies

same main activity, similar in size and age
Company
ESCULAPE Waimes €324,787 €73,113 81.2% -
Docteur FORSTER J-L Jalhay €283,609 €73,781 81.9% -
CABINET MEDICAL DU DOCTEUR LUC PAILLET Herve €321,297 €64,268 94.1% -
Docteur Eric Partoune Dalhem €400,625 €72,349 69.4% -
LIZIN VISION & EYE CENTER Jalhay €268,172 €79,486 94.0% -
BRANORTHO Jalhay €366,295 €65,083 42.5% -
Cabinet médical - Docteur GRITTEN CH. Liège €319,959 €91,480 90.6% -

These companies have the same main activity as ESCULAPE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €268,000 and €401,000, founded between 1993 and 2000.

Official details

Source: KBO
Status
Active since 30-12-1997Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Reachable since 12-01-2026
Company details

Annual accounts 2025

≈ €160,000estimated
€324,787▼ 0.5%
Filing
Filed on 16-09-2026
Financials

Insights on ESCULAPE

ESCULAPE files the micro format. That format states no turnover. The gross margin fell from €75,115 in 2006 to €73,113 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ESCULAPE

What is the company number of ESCULAPE?
The company number of ESCULAPE is 0462.295.367. The VAT number is the same number with BE in front: BE 0462.295.367.
Where is ESCULAPE based?
The registered office is at Rue du Vivier 37, 4950 Waimes.Company details
What does ESCULAPE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ESCULAPE?
ESCULAPE is a private limited company (BV).
When was ESCULAPE founded?
ESCULAPE was founded on 30-12-1997.
Is ESCULAPE still active?
Yes, ESCULAPE is an active enterprise in the KBO register.
What is the turnover of ESCULAPE?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €73,113 and 32 comparable companies (NACE 862). It probably lies between €130,000 and €210,000.Financials
Is ESCULAPE profitable?
In financial year 2025, ESCULAPE made a profit of €23,522.
Where can I find the annual accounts of ESCULAPE?
ESCULAPE filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ESCULAPE due?
ESCULAPE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.